Oragenics Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Oragenics Stock Summary

Oragenics competes with Tonix Pharmaceuticals, Jaguar Animal, and Avinger. Oragenics, Inc. develops antibiotics for infectious diseases in the United States. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida. Oragenics operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.

Oragenics Key Financial Ratios

Oragenics Key Balance Sheet Accounts

Oragenics Key Income Statement Accounts

Oragenics Key Cash Accounts

Oragenics Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Oragenics's current stock value. Our valuation model uses many indicators to compare Oragenics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Oragenics competition to find correlations between indicators driving Oragenics's intrinsic value. More Info.Oragenics is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . At this time, Oragenics' Return On Equity is very stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Oragenics' earnings, one of the primary drivers of an investment's value.

Oragenics Systematic Risk

Today, most investors in Oragenics Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Oragenics' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Oragenics growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Oragenics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Oragenics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Oragenics based on widely used predictive technical indicators. In general, we focus on analyzing Oragenics Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Oragenics's daily price indicators and compare them against related drivers.

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Oragenics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income. To learn how to invest in Oragenics Stock, please use our How to Invest in Oragenics guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oragenics. If investors know Oragenics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oragenics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Oragenics is measured differently than its book value, which is the value of Oragenics that is recorded on the company's balance sheet. Investors also form their own opinion of Oragenics' value that differs from its market value or its book value, called intrinsic value, which is Oragenics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oragenics' market value can be influenced by many factors that don't directly affect Oragenics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Oragenics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Oragenics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oragenics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.